How Xarelto Lawsuit Loans Work
TriMark specializes in helping personal injury victims. Our pre settlement funding is a simple 3-step process:
Apply online or by phone; it’s fast, free, and easy. We’ll answer all your questions, and there is no obligation.
Your dedicated TriMark representative will work with your attorney to review your case. No hassle. Guaranteed.
Receive $500 to $500K+ within 24 hours of approval by wire transfer or FedEx Overnight. It’s that simple.
TriMark Legal Funding has been helping plaintiffs who need financial assistance through affordable non-recourse pre settlement funding for 17 years now. We offer Xarelto lawsuit loans to victims who are waiting to settle their claims against Johnson & Johnson and Bayer.
If you are a plaintiff waiting for the settlement from Johnson & Johnson and Bayer, you might be having financial difficulties due to out-of-pocket costs incurred during your medication and treatment. If this is your situation, TriMark’s Xarelto lawsuit loans may be the solution to your financial problem.
Lawsuits were filed against multinational companies Johnson & Johnson and Bayer due to reports that they had been profiting from the sales of a dangerous drug while patients had sustained side effects. Both companies continue to claim that the drug is not defective.
The high-profile multi-district litigation cases are yet to close, and the prolonged waiting might have put the victims’ finances in jeopardy.
We understand how stressful it can be to for you to hope for a smooth recovery but couldn’t because of financial restraints.
It may take more months or years to materialize. TriMark’s Xarelto lawsuit loans offer an alternative to plaintiffs looking for funds to cover emergency costs and daily expenses.
Xarelto Settlement Loans
While negotiations are underway, you can advance a portion of your future check through a Xarelto lawsuit loan. Unlike traditional loans, this financial lifeline is a non-recourse, risk-free cash advance that plaintiffs can leverage during hard times. Apply for as high as 20% to 50% without worrying about steep interests.
Get a Xarelto lawsuit loan quickly by tomorrow and use it on your treatment and recovery costs, daily expenses, mortgage, car loan, and other needs that may arise during the waiting period.
This option comes with no out-of-pocket costs and monthly payments. You only pay back the advance if you win a jury award or settlement. If your case loses or does not settle, you won’t have to return the full amount.
At TriMark, we assume all the risks. But we also approve cases based on their merits. Meaning, credit scores, income history, and employment status have no bearing on our decision.
It is pretty safe, easy, and convenient to choose legal funding? Apply for a Xarelto lawsuit loan now and see for yourself!
Get a Xarelto Lawsuit Loan Now
TriMark’s Xarelto lawsuit loan application process is fast and simple.
You can either fill out an online form or call us at 1-(877) 932-2628 and let one of our friendly legal funding experts receive your application. The approval of your funding request will be based on the merits of your case, so make sure to submit your complete documents.
After you’re approved, the funds will be transferred to you in as quick as 24 hours!
TriMark seeks to bring you financial relief, so grab this opportunity and apply now.
How to Qualify for Xarelto Settlement Loans
Pre settlement and post settlement Xarelto lawsuit loans are two types of lawsuit financing provided by TriMark. They refer to funding for people with active and settled cases.
If you’re one of the more than 23,000 pending Xarelto cases, you qualify for pre settlement Xarelto lawsuit loans. Here are the criteria you must fulfill to ensure 100% approval:
- A contingent-fee attorney represents you.
- You must have sustained significant injuries from the train accident.
- Your anticipated value should net at least $150,000 (gross award less attorney fees, case costs, medical liens, etc.).
- Your settlement check must be deposited to, and be distributed out of, your attorney’s trust account.
Most personal injury suits are eligible for post settlement Xarelto lawsuit loans. Make sure your net minimum value is $60,000 and relevant documentation submitted for faster processing.
What is Xarelto?
Xarelto is an anticoagulant, more commonly known as a blood thinner, that treats pulmonary embolism (PE) and prevents or treats deep vein thrombosis (DVT), a particular type of blood clot. It reduces the risk of blood clots in people who had knee or hip replacement surgery and risk of stroke in patients with a heart rhythm disorder called atrial fibrillation.
The oral medication works by blocking specific proteins found in the blood.
Under the generic name rivaroxaban, the drug was developed by Bayer but marketed in the U.S. by Janssen Pharmaceuticals, a Johnson & Johnson subsidiary. It was patented in 2007 and approved by the Food and Drug Administration (FDA) in 2011 after an expedited regulatory review.
Xarelto was introduced as one of the novel oral anticoagulants on the market, advertised as safe and a better, more convenient alternative to warfarin.
This situation remains despite the thousands of lawsuits filed against the drug firms responsible for its development and distribution. Plaintiffs have alleged that these companies are profiting from the sales of a risky drug. One of the common side effects of Xarelto is bleeding, which could lead to death in some cases.
Traditional anticoagulants usually have an antidote in the form of vitamin K. But no affordable antidote currently exists to counteract the adverse effects of rivaroxaban, which poses another problem.
The FDA is yet to recall Xarelto. But it has released warnings regarding its use, including the increased risk of blood clots in users who abruptly stop taking it.
Danger, Danger: Bayer’s Blood Thinner
The FDA issued a black box warning for Xarelto, indicating its dangers for spinal bleeding or epidural or spinal hematomas. Hematomas are pools of blood that happen outside of the blood vessels. If they occur in the spine, the patient could be permanently paralyzed.
Blood thinners are naturally dangerous, but Bayer’s anticoagulant was the number one on the list of most dangerous published by the Institute for Safe Medication Practices (ISMP).
The drug is also part of a list of “high-alert medications,” basically stating that when misused, the drug can increase the risk of severe harm to patients.
Symptoms & Side Effects
The use of Xarelto comes with various symptoms and side effects. The most alarming is bleeding, but it can range from mild to severe. Because the drug’s main job is to stop blood clot formation, continuous bleeding may occur even in the smallest cuts, which could ultimately be fatal.
Below are more side effects of this medication. Take note that this list is incomplete, so contact your doctor immediately if other side effects occur.
- Minor Bleeding: Bleeding from cuts and nosebleed are considered mild signs. But if they persist, let your doctor know promptly.
- Severe Bleeding: Serious symptoms may include unusual bruising, pain and swelling, menstrual flow (heavy or prolonged), and weakness. It’s also time to call your physician if you’re bleeding more frequently in the nose, from cuts, while coughing, and while pooping.
Extreme headaches, difficulty breathing or swallowing, and dizziness and fainting also fall under this category.
- Allergic Reaction: This symptom is rare. But if you’re manifesting an allergic reaction, such as itching, rash, extreme dizziness, and breathing difficulty, seek medical attention immediately.
- Other Serious Side Effects: Heavy bleeding can come with confusion, slurred speech, vision changes, and weakness, especially on one side of the body.
According to WebMD, some people using Xarelto do not experience severe side effects. Thus, if your doctor prescribes it to you, he or she likely finds the benefits more significant than the risk of side effects.
Lawsuits & Litigation
More than 25,000 lawsuits were filed against Jannsen Pharmaceuticals, Johnson & Johnson, and Bayer, all of which were consolidated in multidistrict litigation (MDL) in a Louisiana federal court. The MDL is known as MDL-2592 IN RE: Xarelto (Rivaroxaban) Products Liability Litigation. U.S. District Court Judge Eldon E. Fallon oversees the trials.
The plaintiffs accuse the three companies of negligence due to failing to research the blood clot medication adequately. The suits also say the defendant downplayed the consequences of taking the drug. Users claim they suffered from internal bleeding and hemorrhagic strokes.
However, Xarelto’s makers won in the first three bellwether trials.
Joseph Boudreaux, a 75-year-old patient from Louisiana, took Xarelto for his heart condition. He was then hospitalized for gastrointestinal bleeding.
The jury came up with a verdict against his case.
Joseph Orr alleged that Xarelto’s manufacturers were responsible for the death of his wife, Sharyn Orr. Also from Louisiana, Sharlyn Orr experienced a hemorrhagic stroke after taking Xarelto, falling in a coma for 10 days before passing away.
Bayer and Jannsen won the trial.
Dora Mingo developed deep vein thrombosis after hip surgery and was prescribed Xarelto. The medication resulted in gastrointestinal bleeding and acute blood loss.
The jury favored the manufacturers, and the court denied Mingo’s motion for a new trial.
Overall, Xarelto’s makers already faced six trials, which they all won.
In a Philadelphia state court, a jury awarded nearly $27.8 million to 75-year-old Lynn Hartman from Indiana woman over the failure of Xarelto’s makers to warn users about the risks associated with their anticoagulant.
Hartman used Xarelto to treat atrial fibrillation for a year, leading to gastrointestinal bleeding.
However, the trial judge overturned the verdict in favor of the firms.
DrugWatch reports that Johnson & Johnson and Bayer had 23,866 pending MDL cases as of April 2019. A month before that, the two pharmaceutical giants announced they would settle a majority of the remaining suits for $775 million.
According to the terms of the agreement, both firms ensured the safety of the drug and claimed no liability.
If you have a pending Xarelto case, it will be settled on the following basis:
- There will be a significant reduction of payment for people who were prescribed Xarelto on or after December 1, 2015. The same term applies to those who first experienced a Xarelto-related injury on or before March 1, 2016.
- Payments will be capped for patients who got hospitalized for two consecutive days or less for an injury incurred after taking Xarelto.
- Individuals with a Xarelto lawsuit can still join the settlement if they retained an attorney before March 11, 2019, registered their claim by March 28, 2019, and filed a lawsuit by April 4, 2019.
How to Apply for Xarelto Settlement Funding
Here at TriMark, we aim to provide our clients with topnotch financing products and convenient processes. Our 3-step Xarelto lawsuit loan application represents our mission and beliefs:
- You have two options. First, fill out an online form. The entire thing lasts only for a couple of minutes. Or second, call us to talk with one of our friendly legal funding experts, who will gladly process your application.
- Allow us to assess your application within 24 to 72 hours. We will base our decision on the merits of your case, so make sure to submit documents completely.
- Receive your application result via call or message. If your funding request is approved, your funds will be disbursed through your chosen channel in as fast as one to 24 hours.
Apply now or call and speak with one of our friendly funding experts.
Cases We Fund
TriMark can consider funding on nearly any type of lawsuit with clear liability against a sufficiently insured defendant. We proudly feature some of the most attractive rates in the industry.